Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi !

Approaches and considerations for the succesfull treatment of HCV infection. (CROSBI ID 653382)

Prilog sa skupa u zborniku | sažetak izlaganja sa skupa | međunarodna recenzija

Smolić, Robert Approaches and considerations for the succesfull treatment of HCV infection.. 2017

Podaci o odgovornosti

Smolić, Robert

engleski

Approaches and considerations for the succesfull treatment of HCV infection.

Treatment of hepatitis C (HCV) infection is very comprehensive and includes necessity for great efforts from the patient and the physician. This complexity is in accordance with numerous features of HCV infection itself. Many factors affect progression of HCV infection, such as patient characteristic, social factors, characteristics of virus, as well as the timing of initiation, duration and final results of the therapy. The first treatment approved for patients with chronic HCV, interferon-alfa-2b, had a sustained viral response (SVR) rate of 20%. Additionally, 80% of patients treated with interferon-based therapy experience side effects. Therefore, a patient-tailored approach with various medical disciplines working together and intervening at the right time to minimize potential obstacles was required. Consequently, with a number of interferon-free treatment options available, the problem of side effects is less significant, but important drug-drug interactions require interdisciplinary consultations. Likewise, high price of DAAs represents a major obstacle, which limits access to treatment. Guidelines and recommendations on treatment of hepatitis C have been developed to assist physicians and other healthcare providers to determine priority. The importance of patient-tailored approach and close patient-physician cooperation, with emphasis on significance of various medical disciplines working together in achieving higher SVR rates will be discussed.

HCV infection ; treatment development ; patient-tailored approach

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o prilogu

2017.

objavljeno

Podaci o matičnoj publikaciji

Podaci o skupu

4th International Monothematic Conference on Viral Hepatitis C (IMC-HCV-2017)

pozvano predavanje

05.10.2017-07.10.2017

Virovitica, Hrvatska

Povezanost rada

Povezane osobe




nije evidentirano